Difference between revisions of "Team:XJTLU-CHINA/Safety"
Kerberos01 (Talk | contribs) |
Kerberos01 (Talk | contribs) |
||
(14 intermediate revisions by 3 users not shown) | |||
Line 78: | Line 78: | ||
padding-bottom: 15px; | padding-bottom: 15px; | ||
background-color: #3399FF; | background-color: #3399FF; | ||
+ | margin-left:-20px; | ||
} | } | ||
Line 231: | Line 232: | ||
padding-bottom: 15px; | padding-bottom: 15px; | ||
background-color: #3399FF; | background-color: #3399FF; | ||
+ | margin-left:-20px; | ||
} | } | ||
Line 310: | Line 312: | ||
font-weight: 600; | font-weight: 600; | ||
padding-top: 111px; | padding-top: 111px; | ||
+ | padding-left:10px; | ||
} | } | ||
Line 316: | Line 319: | ||
font-weight: 600; | font-weight: 600; | ||
padding-top: 5px; | padding-top: 5px; | ||
+ | padding-left:10px; | ||
} | } | ||
+ | |||
.navilogo{ | .navilogo{ | ||
Line 649: | Line 654: | ||
<ul> | <ul> | ||
<li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J1">Map description</a></li> | <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J1">Map description</a></li> | ||
− | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2"> | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2">RNAT</a></li> |
− | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4"> | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4">The second trial of RNAT testing</a></li> |
− | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description# | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J5">Chromo-protein testing</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 670: | Line 675: | ||
<li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J1">Team introduction</a></li> | <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J1">Team introduction</a></li> | ||
<li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J2">Attribution</a></li> | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J2">Attribution</a></li> | ||
+ | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J3">Achievements</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
Line 717: | Line 723: | ||
</div> | </div> | ||
<ul> | <ul> | ||
− | <li><a class="jump1" href=" | + | <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J1">with NYU-Shanghai</a></li> |
− | <li><a class="jump2" href=" | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#synbio">Synbio-tech</a></li> |
+ | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J2">with BIT-China</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
Line 746: | Line 753: | ||
<ul> | <ul> | ||
<li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J1">Map description</a></li> | <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J1">Map description</a></li> | ||
− | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2"> | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2">RNAT</a></li> |
− | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4"> | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4">Improve experiment of RNAT</a></li> |
− | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description# | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J5">Chromo-protein testing</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 767: | Line 774: | ||
<li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J1">Team introduction</a></li> | <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J1">Team introduction</a></li> | ||
<li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J2">Attribution</a></li> | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J2">Attribution</a></li> | ||
+ | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J3">Achievements</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
Line 812: | Line 820: | ||
<li class="ZmainNavi col1"> | <li class="ZmainNavi col1"> | ||
<div id="ZPrimaryNaviBg9"> | <div id="ZPrimaryNaviBg9"> | ||
− | <a class="ZprimaryNavi" href="https://2015.igem.org/Team:XJTLU-CHINA/ | + | <a class="ZprimaryNavi" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations">Collaboration</a> |
</div> | </div> | ||
<ul> | <ul> | ||
− | <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/ | + | <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J1">with NYU-Shanghai</a></li> |
− | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/ | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#synbio">Synbio-tech</a></li> |
+ | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J2">with BIT-China</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
Line 840: | Line 849: | ||
</div> | </div> | ||
<div class="subNavi"> | <div class="subNavi"> | ||
− | <p>Biosafety is probably the most controversial issue in synthetic biology | + | <p>Biosafety is probably the most controversial issue in synthetic biology. Being responsible to everyone, 2015 XJTLU team took variety of measurements to promote the safety in the lab. We reached an agreement and drafted a lab policy. We used low hazard strains to minimize the potential risks of our project.</p> |
− | + | ||
− | + | ||
</div> | </div> | ||
</div> | </div> | ||
Line 861: | Line 868: | ||
<div class="ruleImgText"> | <div class="ruleImgText"> | ||
<p style="font-size: 25px; text-align: center">Policy</p> | <p style="font-size: 25px; text-align: center">Policy</p> | ||
− | + | <p style="font-size: 15px; text-align: center">(Sorry for only Chinese version.)</p> | |
− | + | <p>The policy not only includes the main clauses in safety guideline of laboratory but also add a few special requirements as well as some tips. For instance, “having a good mood” is documented as the top one because keeping your mind clean, clear, positive and free is usually a good way to ensure the correctness and safety of experiments. In order to guarantee the implementation of the policy, we chose one of our team members as a supervisor.</p> | |
− | <p>(Sorry for only Chinese version | + | |
− | + | ||
− | <p>The policy not only includes the main clauses in safety guideline of laboratory but also add a few special requirements as well as tips. For | + | |
</div> | </div> | ||
Line 880: | Line 884: | ||
<div class="lv0"> | <div class="lv0"> | ||
<div class="lv1"> | <div class="lv1"> | ||
− | <h2 STYLE="text-align: center; font-size: 55px; background-color: # | + | <h2 STYLE="text-align: center; font-size: 55px; background-color: #191970; color: #FFFFFF";>Q & A</h2> |
</div> | </div> | ||
</div> | </div> | ||
Line 893: | Line 897: | ||
<div class="lv2" > | <div class="lv2" > | ||
<h3>Researcher Safety</h3> | <h3>Researcher Safety</h3> | ||
− | <div class="lv2-1">Escherichia coli, as an engineering bacterium is the cell line that we normally work with. As an engineering bacterium, it has been documented as a non-hazard microbe and extensively used for decades. The carcinogenic experiment reagents, such as Ethidium bromide the DNA dye, had been replaced by less harmful reagents before initiating the project. Moreover, we | + | <div class="lv2-1"><i>Escherichia coli</i>, as an engineering bacterium, is the cell line that we normally work with. As an engineering bacterium, it has been documented as a non-hazard microbe and extensively used for decades. The carcinogenic experiment reagents, such as Ethidium bromide the DNA dye, had been replaced by less harmful reagents before initiating the project. Moreover, we followed the rules and firmly believe that the safety is always priority to our project.</div> |
<br/> | <br/> | ||
<h3>Public Safety</h3> | <h3>Public Safety</h3> | ||
− | <div class="lv2-1">Our project is only a demonstrated project and is not involved in any direct contact between the bacteria and public. The key is the visual effect caused by the microbes instead of the products of bacteria or bacteria itself. i.e. the biothermomap may only use for non-commercial and non-profit purpose and the bacteria would not be spread out and used by other institutions, except in our lab.</div> | + | <div class="lv2-1">Our project is only a demonstrated project and is not involved in any direct contact between the bacteria and the public. The key is the visual effect caused by the microbes instead of the products of bacteria or bacteria itself. i.e. the biothermomap may only use for non-commercial and non-profit purpose and the bacteria would not be spread out and used by other institutions, except in our lab.</div> |
<br/> | <br/> | ||
<h3>Environmental Safety</h3> | <h3>Environmental Safety</h3> | ||
− | <div class="lv2-1">No. Theoretically, after the demonstration of our project, our bacteria would be disposed of properly and immediately. No further investigations are required. Even if there are experimental bacteria accidentally | + | <div class="lv2-1">No. Theoretically, after the demonstration of our project, our bacteria would be disposed of properly and immediately. No further investigations are required. Even if there are experimental bacteria accidentally entering natural environment, they are highly unlikely to pose a threat given the overloaded bacteria and the harmless nature of themselves.</div> |
<br/> | <br/> | ||
</div> | </div> | ||
Line 917: | Line 921: | ||
<h2>Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues?</h2> | <h2>Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues?</h2> | ||
<div class="lv2" > | <div class="lv2" > | ||
− | <div class="lv2-1">No. we | + | <div class="lv2-1">No. we did not use any new BioBrick parts. All BioBrick parts were derived from the previous iGEM team or the literature and which all had been expressed in <i>E. coli</i> previously and no hazardous conclusion was drawn. The only difference is that integrating various protein genes into one construction forms a relatively complicated bacteria internal environment, which is inclined to weaken the cells.</div> |
</div> | </div> | ||
</div> | </div> | ||
Line 934: | Line 938: | ||
<h2>Is there a local biosafety group, committee, or review board at your institution? If yes, what does your local biosafety group think about your project?</h2> | <h2>Is there a local biosafety group, committee, or review board at your institution? If yes, what does your local biosafety group think about your project?</h2> | ||
<div class="lv2" > | <div class="lv2" > | ||
− | <div class="lv2-1">No. To be honest, there is NO any biosafety-related group, committee, or review board at our institution. This is probably a universal answer for Chinese biological institutions. We wouldn’t dare to affirm that Chinese government completely neglects the biosafety issue but can tell that the economic benefits always outweigh the costs on the biosafety in the view of a vast majority of proprietors. Fortunately, in our lab, there is a strict safety assessment procedure devised by the lab managers and which is fully capable of ensuring the safety of | + | <div class="lv2-1">No. To be honest, there is NO any biosafety-related group, committee, or review board at our institution. This is probably a universal answer for Chinese biological institutions. We wouldn’t dare to affirm that Chinese government completely neglects the biosafety issue but can tell that the economic benefits always outweigh the costs on the biosafety in the view of a vast majority of proprietors. Fortunately, in our lab, there is a strict safety assessment procedure devised by the lab managers and which is fully capable of ensuring the safety of the researchers. All in all, biosafety is an oversight that we normally have in China. We are obligatory on improving the understanding of the importance of biosafety and in order to change the situation in a large scale, we are hereby looking forward to the assistance of Chinese government.</div> |
</div> | </div> | ||
</div> | </div> | ||
Line 971: | Line 975: | ||
<div class="footer"> | <div class="footer"> | ||
<div class="footerBg"> | <div class="footerBg"> | ||
− | <div class="container" style="text-align: center"> | + | <div class="container" style="text-align: center; padding-top: 40px;"> |
<img class="logo" src="https://static.igem.org/mediawiki/2015/d/da/LogoXJTLU15.png" height="53"> | <img class="logo" src="https://static.igem.org/mediawiki/2015/d/da/LogoXJTLU15.png" height="53"> | ||
<img class="logo" src="https://static.igem.org/mediawiki/2015/9/96/Logo2XJTLU15.png" height="50"> | <img class="logo" src="https://static.igem.org/mediawiki/2015/9/96/Logo2XJTLU15.png" height="50"> | ||
− | <img class="logo" src="https://static.igem.org/mediawiki/2015/e/e3/%E6%B3%93%E8%BF%85%E7%A7%91%E6%8A%80Synbio_Technologies_Logo.png" height="50 | + | <img class="logo" src="https://static.igem.org/mediawiki/2015/e/e3/%E6%B3%93%E8%BF%85%E7%A7%91%E6%8A%80Synbio_Technologies_Logo.png" height="50" > |
<br/> | <br/> | ||
<img class="logo" src="https://static.igem.org/mediawiki/2015/4/41/AgilentXJTLU15.png" height="50" style="margin-top:60px;"> | <img class="logo" src="https://static.igem.org/mediawiki/2015/4/41/AgilentXJTLU15.png" height="50" style="margin-top:60px;"> |
Latest revision as of 16:16, 4 October 2015
XJTLU-CHINA
Saftey
Biosafety is probably the most controversial issue in synthetic biology. Being responsible to everyone, 2015 XJTLU team took variety of measurements to promote the safety in the lab. We reached an agreement and drafted a lab policy. We used low hazard strains to minimize the potential risks of our project.
Policy
(Sorry for only Chinese version.)
The policy not only includes the main clauses in safety guideline of laboratory but also add a few special requirements as well as some tips. For instance, “having a good mood” is documented as the top one because keeping your mind clean, clear, positive and free is usually a good way to ensure the correctness and safety of experiments. In order to guarantee the implementation of the policy, we chose one of our team members as a supervisor.